Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
Abstract Background There is limited data on the use of targeted or immunotherapy (TT/IT) in combination with single fraction stereotactic radiosurgery (SRS) in patients with melanoma brain metastasis (MBM). Therefore, we analyzed the outcome and toxicity of SRS alone compared to SRS in combination...
Main Authors: | Indrawati Hadi, Olarn Roengvoraphoj, Raphael Bodensohn, Jan Hofmaier, Maximilian Niyazi, Claus Belka, Silke Birgit Nachbichler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-020-1485-8 |
Similar Items
-
Early Results of Stereotactic Radiosurgery in Uveal Melanoma and Risk Factors for Radiation Retinopathy
by: Gökçen Özcan, et al.
Published: (2020-06-01) -
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
by: Giuseppe Minniti, et al.
Published: (2019-04-01) -
Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective
by: Jakob Liermann, et al.
Published: (2020-10-01) -
Single isocenter stereotactic radiosurgery for patients with multiple brain metastases: dosimetric comparison of VMAT and a dedicated DCAT planning tool
by: Jan Hofmaier, et al.
Published: (2019-06-01) -
«GAMMA-KNIFE» STEREOTACTIC RADIOSURGERY FOR LARGE UVEAL MELANOMA AS AN ALTERNATIVE FOR ENUCLEATION (FIRST RESULTS)
by: A. A. Yarovoy, et al.
Published: (2015-10-01)